LUV
48
3
URBN
67
5
AFL
49
3
HAL
53
2
CSX
68
3
CA
25
3
VRTX
62
-6
EL
18
3
TGNA
62
-2
JNPR
54
-2
UPS
41
-4
PX
79
6
LOW
58
2
ICE
62
3
AA
57
-6
MAT
51
-4
CNP
46
-4
SRE
69
3
EXC
37
2
WFC
82
7
LUV
48
3
URBN
67
5
AFL
49
3
HAL
53
2
CSX
68
3
CA
25
3
VRTX
62
-6
EL
18
3
TGNA
62
-2
JNPR
54
-2
UPS
41
-4
PX
79
6
LOW
58
2
ICE
62
3
AA
57
-6
MAT
51
-4
CNP
46
-4
SRE
69
3
EXC
37
2
WFC
82
7
Financhill
Back

Revance Therapeutics Quote, Financials, Valuation and Earnings

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Sell
4

RVNC
Revance Therapeutics

Last Price:
4.13
Seasonality Move:
7.02%

7 Day Trial

ALL ACCESS PASS

$ 7

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here

Revance Therapeutics Price Quote

$4.13
+0.69 (+20.06%)
(Updated: November 12, 2024 at 5:55 PM ET)

Revance Therapeutics Key Stats

Sell
4
Revance Therapeutics (RVNC) is a Sell
Day range:
$3.36 - $3.90
52-week range:
$2.30 - $9.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.30
P/B ratio:
0%
Volume:
6.2M
Avg. volume:
2.1M
1-year change:
-42.38%
Market cap:
$360.9M
Revenue:
$234M
EPS:
$-1.94

How Much Does Revance Therapeutics Make?

Is Revance Therapeutics Growing As A Company?

  • What Is Revance Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.11%
  • What Is Revance Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Revance Therapeutics Stock Price Performance

What Is Revance Therapeutics 52-Week High & Low?

Revance Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Revance Therapeutics?

Is Revance Therapeutics Cash Flow Positive?

  • What Is RVNC Cash Flow From Operations?
    Cash flow from operations (TTM) is -$190.9M
  • What Is Revance Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $81.7M
  • What Is Revance Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$12.9M

Revance Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    RVNC return on invested capital is -61.49%
  • What Is Revance Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -37.25%
  • What Is RVNC Return On Equity?
    ROE is a measure of profitability and is 0%

Revance Therapeutics Earnings Date & Stock Price

Revance Therapeutics Competitors

Revance Therapeutics Dividend Yield

Revance Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 6.33%
Revenue: 10.66% -12.17%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 8
Sell Recommendations: 0
Price Target: 9.23
Upside from Last Price: 168.19%

Major Shareholders

  • How many RVNC shares are owned by institutional investors?
    127.4M RVNC shares are owned by institutional investors
  • How many RVNC shares are owned by insiders?
    2.7M RVNC shares are owned by insiders